CDKI-73

CDKI-73
Item number Size Datasheet Manual SDS Delivery time Quantity Price
TGM-T14919-1mg 1 mg

7 - 10 business days*

143.00€
TGM-T14919-2mg 2 mg

7 - 10 business days*

193.00€
TGM-T14919-5mg 5 mg

7 - 10 business days*

301.00€
TGM-T14919-1mL 1 ml

7 - 10 business days*

316.00€
TGM-T14919-10mg 10 mg

7 - 10 business days*

433.00€
TGM-T14919-25mg 25 mg

7 - 10 business days*

717.00€
TGM-T14919-50mg 50 mg

7 - 10 business days*

967.00€
TGM-T14919-100mg 100 mg

7 - 10 business days*

1,363.00€
 
Description: CDKI-73 is a potent CDK9 inhibitor (Ki: 4 nM). It shows selective toxicity to CLL... more
Product information "CDKI-73"
Description: CDKI-73 is a potent CDK9 inhibitor (Ki: 4 nM). It shows selective toxicity to CLL cells(LD50=80 nM) versus normal B cell and normal CD34+ cell(LD50>20 uM).The inhibition of CDK9 induces apoptosis and potentiates the effect of cisplatin. Target: Apoptosis, CDK. Smiles: CNc1nc(C)c(s1)-c1nc(Nc2cccc(c2)S(N)(=O)=O)ncc1F. References: Xie S, et al. Antitumor action of CDK inhibitor LS-007 as a single agent and in combination with ABT-199 against human acute leukemia cells. Acta Pharmacol Sin. 2016 Nov,37(11):1481-1489.
Supplier: TargetMol
Supplier-Nr: T14919

Properties

Application: Cdk9-cyclin T1 / Cdk1-cyclin B / Cdk2-cyclin A inhibitor
MW: 394.45 D
Formula: C15H15FN6O2S2

Database Information

CAS : 1421693-22-2| Matching products
KEGG ID : K02206 | Matching products

Handling & Safety

Storage: +4°C
Shipping: +4°C (International: +4°C)
Caution
Our products are for laboratory research use only: Not for administration to humans!
Information about the product reference will follow. more
You will get a certificate here
or to request a certificate of analysis.
Read, write and discuss reviews... more
Customer review for "CDKI-73"
Write a review
or to review a product.
Viewed